<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glazmag</journal-id><journal-title-group><journal-title xml:lang="ru">The EYE ГЛАЗ</journal-title><trans-title-group xml:lang="en"><trans-title>The EYE GLAZ</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2222-4408</issn><issn pub-type="epub">2686-8083</issn><publisher><publisher-name>Академия медицинской оптики и оптометрии</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33791/2222-4408-2026-2-114-121</article-id><article-id custom-type="elpub" pub-id-type="custom">glazmag-816</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Нарушения микроциркуляции конъюнктивы и сетчатки у больных гипертонической болезнью</article-title><trans-title-group xml:lang="en"><trans-title>Microcirculatory abnormalities of the conjunctiva and retina in patients with arterial hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-9530-3094</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Энхтайван</surname><given-names>Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Enkhtaivan</surname><given-names>B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Энхтайван Байгаль, аспирант кафедры госпитальной терапии № 1 Института клинической медицины им. Н.В. Склифосовского</p><p>119048, г. Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Baigali Enkhtaivan, Postgraduate Student, Department of Hospital Therapy No. 1, Sklifosovsky Institute of Clinical Medicine</p><p>8 Trubetskaya St., bldg. 2, Moscow, 119048</p></bio><email xlink:type="simple">baigal_1026@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9744-9183</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юсупова</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Yusupova</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юсупова Альфия Оскаровна, кандидат медицинских наук, профессор, зав. учебной частью кафедры госпитальной терапии № 1 Института клинической медицины им. Н.В. Склифосовского</p><p>119048, г. Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Alfiya O. Yusupova, Cand. Sci. (Med.), Professor, Head of Academic Affairs, Department of Hospital Therapy No. 1, Sklifosovsky Institute of Clinical Medicine</p><p>8 Trubetskaya St., bldg. 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1172-1116</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Слепова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Slepova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Слепова Ольга Александровна, кандидат медицинских наук, ассистент кафедры госпитальной терапии № 1 Института клинической медицины им. Н.В. Склифосовского </p><p>119048, г. Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Olga A. Slepova, Cand. Sci. (Med.), Assistant, Department of Hospital Therapy No. 1, Sklifosovsky Institute of Clinical Medicine</p><p>8 Trubetskaya St., bldg. 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0113-8768</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пахтусов</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Pakhtusov</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пахтусов Николай Николаевич, кандидат медицинских наук, ассистент кафедры госпитальной терапии № 1 Института клинической медицины им. Н.В. Склифосовского </p><p>119048, г. Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Nikolay N. Pakhtusov, Cand. Sci. (Med.), Assistant, Department of Hospital Therapy No. 1, Sklifosovsky Institute of Clinical Medicine</p><p>8 Trubetskaya St., bldg. 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3014-6129</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Беленков</surname><given-names>Ю. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Belenkov</surname><given-names>Yu. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Беленков Юрий Никитич, доктор медицинских наук, член-корреспондент РАН, академик РАН, профессор, зав. кафедрой госпитальной терапии № 1 Института клинической медицины им. Н.В. Склифосовского</p><p>119048, г. Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Yuri N. Belenkov, Dr. Sci. (Med.), Corresponding Member of the Russian Academy of Sciences, Academician of the Russian Academy of Sciences, Professor, Head of the Department of Hospital Therapy No. 1, Sklifosovsky Institute of Clinical Medicine</p><p>8 Trubetskaya St., bldg. 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8438-1872</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сипливый</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Siplivy</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сипливый Владимир Иванович, кандидат медицинских наук, доцент кафедры глазных болезней</p><p>119048, г. Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Vladimir I. Siplivy, Cand. Sci. (Med.), Associate Professor, Department of Eye Diseases</p><p>11 A, B Rossolimo St., Moscow, 119021</p></bio><email xlink:type="simple">siplivyy_v_i@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4601-0904</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сафонова</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Safonova</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сафонова Татьяна Николаевна, кандидат медицинских наук, ведущий научный сотрудник отдела патологии слезного аппарата </p><p>119021, г. Москва, ул. Россолимо, 11 А, Б</p></bio><bio xml:lang="en"><p>Tatiana N. Safonova, Cand. Sci. (Med.), Leading Researcher, Department of Lacrimal System Pathology</p><p>11 A, B Rossolimo St., Moscow, 119021</p></bio><email xlink:type="simple">safotat@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2740-2793</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кинтюхина</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kintyukhina</surname><given-names>N. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кинтюхина Наталия Павловна, кандидат медицинских наук, научный сотрудник отдела патологии слезного аппарата</p><p>119021, г. Москва, ул. Россолимо, 11 А, Б</p></bio><bio xml:lang="en"><p>Nataliya P. Kintyukhina, Cand. Sci. (Med.), Researcher, Department of Lacrimal System Pathology</p><p>11 A, B Rossolimo St., Moscow, 119021</p></bio><email xlink:type="simple">natakint@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-7055-0373</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алтемирова</surname><given-names>Х. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Altemirova</surname><given-names>Kh. Kh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алтемирова Хадишат Хамидовна, врач-офтальмолог отделения диагностических исследований</p><p>119021, г. Москва, ул. Россолимо, 11 А, Б</p></bio><bio xml:lang="en"><p>Khadishat K. Altemirova, Ophthalmologist, Diagnostic Examinations Department, Research Institute of Eye Diseases</p><p>11 A, B Rossolimo St., Moscow, 119021</p></bio><email xlink:type="simple">altemirovah@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnov Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт глазных болезней имени М.М. Краснова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnov Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>29</day><month>06</month><year>2026</year></pub-date><volume>28</volume><issue>2</issue><fpage>114</fpage><lpage>121</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Академия медицинской оптики и оптометрии, 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Академия медицинской оптики и оптометрии</copyright-holder><copyright-holder xml:lang="en">Академия медицинской оптики и оптометрии</copyright-holder><license xlink:href="https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.theeyeglaz.com/jour/article/view/816">https://www.theeyeglaz.com/jour/article/view/816</self-uri><abstract><p>Введение. Гипертоническая болезнь (ГБ) сопровождается развитием системной микроциркуляторной дисфункции, которая является одним из ранних патогенетических звеньев поражения органов-мишеней, в том числе при достижении целевых уровней артериального давления. Микроциркуляция глаза, высокочувствительная к системным гемодинамическим и метаболическим изменениям, рассматривается как доступная модель для неинвазивной оценки состояния микроциркуляторного русла. Цель исследования: оценить нарушения микроциркуляции конъюнктивы и сетчатки у больных гипертонической болезнью. Материалы и методы. В одноцентровое обсервационное исследование в период с ноября 2023 г. по октябрь 2025 г. включены 22 пациента с ГБ I–III стадии и 30 здоровых добровольцев. Всем участникам выполнены лазерная доплеровская флоуметрия (ЛДФ) конъюнктивы и оптическая когерентная томография с ангиографией (ОКТ-А) макулярной области с анализом плотности сосудистого сплетения, параметров перфузии и площади фовеальной аваскулярной зоны. Результаты. У пациентов с ГБ (n = 22) по сравнению с контролем (n = 30) выявлено снижение перфузии (М) конъюнктивы (19,88 ± 2,94 vs 21,80 ± 1,17 п. е., p = 0,001), вариабельности (σ) кровотока (2,04 ± 0,78 vs 4,91 ± 0,20 п. е., p &lt; 0,001) и эндотелиального компонента регуляции (5,6 ± 0,56 % vs 9,67 ± 3,34 %, p = 0,001). По данным ОКТ-А у пациентов с ГБ отмечено снижение плотности поверхностного капиллярного сплетения сетчатки (48,19 ± 1,59 % vs 49,06 ± 0,85 %, p = 0,01) и увеличение межглазной асимметрии этого показателя (4,00 ± 4,42 % vs 2,06 ± 1,62 %, p = 0,016). Установлены корреляционные связи между М и параметрами микроциркуляции сетчатки (r от –0,348 до 0,367; p &lt; 0,05). Заключение. Современные методы ОКТ-А и ЛДФ позволяют комплексно оценить структурные и функциональные параметры микроциркуляции. Их совместное применение дает возможность выявлять ранние признаки сосудистого ремоделирования у пациентов с гипертонической болезнью, что может использоваться для мониторинга поражения органов-мишеней.</p></abstract><trans-abstract xml:lang="en"><p>Background. Arterial hypertension is associated with systemic microcirculatory dysfunction, which represents one of the early pathogenetic mechanisms of target organ damage, even in patients who have achieved target blood pressure levels. Ocular microcirculation, which is highly sensitive to systemic hemodynamic and metabolic changes, is regarded as an accessible model for noninvasive assessment of the microvascular bed. Purpose: To assess abnormalities of conjunctival and retinal microcirculation in patients with arterial hypertension. Materials and methods. This single-center observational study, conducted from November 2023 to October 2025, included 22 patients with stage I–III arterial hypertension and 30 healthy volunteers. All participants underwent conjunctival laser Doppler flowmetry (LDF) and optical coherence tomography angiography (OCTA) of the macular region, including analysis of vessel density, perfusion parameters, and the area of the foveal avascular zone (FAZ). Results. Compared with controls (n = 30), patients with arterial hypertension (n = 22) showed reduced conjunctival perfusion (M) (19.88 ± 2.94 vs 21.80 ± 1.17 perfusion units, p = 0.001), reduced blood flow variability (σ) (2.04 ± 0.78 vs 4.91 ± 0.20 perfusion units, p &lt; 0.001), and a lower endothelial component of regulation (5.6 ± 0.56 % vs 9.67 ± 3.34 %, p = 0.001). OCTA revealed a decrease in the superficial retinal capillary plexus vessel density (48.19 ± 1.59 % vs 49.06 ± 0.85 %, p = 0.01) and an increase in interocular asymmetry of this parameter (4.00 ± 4.42 % vs 2.06 ± 1.62 %, p = 0.016) in patients with arterial hypertension. Correlations were found between M and retinal microcirculatory parameters (r ranging from −0.348 to 0.367; p &lt; 0.05). Conclusion. CTA and LDF provide complementary information on structural and functional microcirculatory changes. Their combined use may help detect early vascular remodeling in patients with arterial hypertension and support monitoring of target organ damage.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гипертоническая болезнь</kwd><kwd>эндотелиальная дисфункция</kwd><kwd>микроциркуляция конъюнктивы</kwd><kwd>микроциркуляция сетчатки</kwd><kwd>лазерная доплеровская флоуметрия</kwd><kwd>оптическая когерентная томография с ангиографией</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>endothelial dysfunction</kwd><kwd>conjunctival microcirculation</kwd><kwd>retinal microcirculation</kwd><kwd>laser Doppler flowmetry</kwd><kwd>optical coherence tomography angiography</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">авторы не получали финансирования при проведении исследования и написании статьи.</funding-statement><funding-statement xml:lang="en">The authors received no funding for the research or the preparation of this article.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Стрельцова НН, Васильев АП. Функциональное состояние микрососудистого русла кожи по данным лазерной допплеровской флоуметрии у пациентов с артериальной гипертонией и при ее сочетании с гиперхолестеринемией. Регионарное кровообращение и микроциркуляция. 2022;21(4):16–24. doi: 10.24884/1682-6655-2022-21- 4-16-24</mixed-citation><mixed-citation xml:lang="en">Streltsova NN, Vasiliev AP. Functional state of skin microvascular bed according to laser doppler flowmetry in patients with arterial hypertension combined with hypercholesterolemia. Regional blood circulation and microcirculation. 2022;21(4):16–24. (In Russ.) doi: 10.24884/1682-6655-2022-21-4-16-24</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rizzoni D, Agabiti-Rosei C, De Ciuceis C. State of the Art Review: Vascular Remodeling in Hypertension. Am J Hypertens. 2023;36(1):1–13. doi: 10.1093/ajh/hpac093</mixed-citation><mixed-citation xml:lang="en">Rizzoni D, Agabiti-Rosei C, De Ciuceis C. State of the Art Review: Vascular Remodeling in Hypertension. Am J Hypertens. 2023;36(1):1–13. doi: 10.1093/ajh/hpac093</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Drożdż D, Drożdż M, Wójcik M. Endothelial dysfunction as a factor leading to arterial hypertension. Pediatr Nephrol. 2023;38(9):2973–2985. doi: 10.1007/s00467-022-05802-z</mixed-citation><mixed-citation xml:lang="en">Drożdż D, Drożdż M, Wójcik M. Endothelial dysfunction as a factor leading to arterial hypertension. Pediatr Nephrol. 2023;38(9):2973–2985. doi: 10.1007/s00467-022-05802-z</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Deepshikha, Mathur P, Monika, et al. An Overview of Hypertension: Pathophysiology, Risk Factors, and Modern Management. Curr Hypertens Rev. 2025;21(2):64–81. doi: 10.2174/0115734021349254250224074832</mixed-citation><mixed-citation xml:lang="en">Deepshikha, Mathur P, Monika, et al. An Overview of Hypertension: Pathophysiology, Risk Factors, and Modern Management. Curr Hypertens Rev. 2025;21(2):64–81. doi: 10.2174/0115734021349254250224074832</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lee WH, Park JH, Won Y, et al. Retinal Microvascular Change in Hypertension as measured by Optical Coherence Tomography Angiography. Sci Rep. 2019;9(1):156. Published 2019 Jan 17. doi: 10.1038/s41598-018-36474-1</mixed-citation><mixed-citation xml:lang="en">Lee WH, Park JH, Won Y, et al. Retinal Microvascular Change in Hypertension as measured by Optical Coherence Tomography Angiography. Sci Rep. 2019;9(1):156. Published 2019 Jan 17. doi: 10.1038/s41598-018-36474-1</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Сафонова ТН, Кинтюхина НП, Ярцев ВД. Морфофункциональное обоснование проведения повторных курсов инвазивного лечения хронического блефарита. Вестник офтальмологии. 2021;137(1):21–27. doi: 10.17116/oftalma202113701121</mixed-citation><mixed-citation xml:lang="en">Safonova TN, Kintyukhina NP, Yartsev VD. Morphofunctional substantiation of repeated invasive treatment of chronic blepharitis. Russian Annals of Ophthalmology. 2021;137(1):21– 27. (In Russ.) doi: 10.17116/oftalma202113701121</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ambrosino P, Bachetti T, D’Anna SE, et al. Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension. J Cardiovasc Dev Dis. 2022;9(5):136. doi: 10.3390/jcdd9050136</mixed-citation><mixed-citation xml:lang="en">Ambrosino P, Bachetti T, D’Anna SE, et al. Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension. J Cardiovasc Dev Dis. 2022;9(5):136. doi: 10.3390/jcdd9050136</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Xu S, Ilyas I, Little PJ, et al. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev. 2021;73(3):924– 967. doi: 10.1124/pharmrev.120.000096</mixed-citation><mixed-citation xml:lang="en">Xu S, Ilyas I, Little PJ, et al. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev. 2021;73(3):924– 967. doi: 10.1124/pharmrev.120.000096</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tomiyama H. Vascular function: a key player in hypertension. Hypertens Res. 2023;46(9):2145–2158. doi: 10.1038/s41440-023-01354-3</mixed-citation><mixed-citation xml:lang="en">Tomiyama H. Vascular function: a key player in hypertension. Hypertens Res. 2023;46(9):2145–2158. doi: 10.1038/s41440-023-01354-3</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Del Pinto R, Mulè G, Vadalà M, et al. Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies. Nutrients. 2022;14(11):2200. doi: 10.3390/nu14112200</mixed-citation><mixed-citation xml:lang="en">Del Pinto R, Mulè G, Vadalà M, et al. Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies. Nutrients. 2022;14(11):2200. doi: 10.3390/nu14112200</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Rizzoni D, Agabiti-Rosei C, Boari GEM, Muiesan ML, De Ciuceis C. Microcirculation in Hypertension: A Therapeutic Target to Prevent Cardiovascular Disease? J Clin Med. 2023;12(15):4892. Published 2023 Jul 25. doi: 10.3390/jcm12154892</mixed-citation><mixed-citation xml:lang="en">Rizzoni D, Agabiti-Rosei C, Boari GEM, Muiesan ML, De Ciuceis C. Microcirculation in Hypertension: A Therapeutic Target to Prevent Cardiovascular Disease? J Clin Med. 2023;12(15):4892. Published 2023 Jul 25. doi: 10.3390/jcm12154892</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Cífková R, Harazny JM, Bruthans J, et al. Early vascular damage in retinal microcirculation in arterial hypertension: the Czech post-MONICA study. J Hypertens. 2024;42(3):557–563. doi: 10.1097/HJH.0000000000003637</mixed-citation><mixed-citation xml:lang="en">Cífková R, Harazny JM, Bruthans J, et al. Early vascular damage in retinal microcirculation in arterial hypertension: the Czech post-MONICA study. J Hypertens. 2024;42(3):557–563. doi: 10.1097/HJH.0000000000003637</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rogowska A, Obrycki L, Feber J, Litwin M. Effects of antihypertensive therapy on macro- and microcirculation in adolescents with arterial hypertension – a prospective study. J Hypertens. 2024;42:e254. doi: 10.1097/01.hjh.0001022100.07872.94</mixed-citation><mixed-citation xml:lang="en">Rogowska A, Obrycki L, Feber J, Litwin M. Effects of antihypertensive therapy on macro- and microcirculation in adolescents with arterial hypertension – a prospective study. J Hypertens. 2024;42:e254. doi: 10.1097/01.hjh.0001022100.07872.94</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao T, Laotaweerungsawat S, Chen Y, Liu X, Liu D, Stewart JM. Right versus left eye asymmetry of microvasculature in diabetes revealed by optical coherence tomography angiography. Sci Rep. 2023;13(1):9332. Published 2023 Jun 8. doi: 10.1038/s41598-023-36058-8</mixed-citation><mixed-citation xml:lang="en">Zhao T, Laotaweerungsawat S, Chen Y, Liu X, Liu D, Stewart JM. Right versus left eye asymmetry of microvasculature in diabetes revealed by optical coherence tomography angiography. Sci Rep. 2023;13(1):9332. Published 2023 Jun 8. doi: 10.1038/s41598-023-36058-8</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ebraheim M, Mohamed E, Kamal O, Gazar H, Eleiwa T. Evaluation of foveal avascular zone and macular vessel density in patients with systemic hypertension using optical coherence tomography angiography. Egypt J Hosp Med. 2023;90(1):2283– 2289. doi: 10.21608/ejhm.2023.285689</mixed-citation><mixed-citation xml:lang="en">Ebraheim M, Mohamed E, Kamal O, Gazar H, Eleiwa T. Evaluation of foveal avascular zone and macular vessel density in patients with systemic hypertension using optical coherence tomography angiography. Egypt J Hosp Med. 2023;90(1):2283– 2289. doi: 10.21608/ejhm.2023.285689</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Anjos R, Ferreira A, Barkoudah E, Claggett B, Abegão Pinto L, Miguel A. Application of Optical Coherence Tomography Angiography Macular Analysis for Systemic Hypertension. A Systematic Review and Meta-analysis. Am J Hypertens. 2022;35(4):356–364. doi: 10.1093/ajh/hpab172</mixed-citation><mixed-citation xml:lang="en">Anjos R, Ferreira A, Barkoudah E, Claggett B, Abegão Pinto L, Miguel A. Application of Optical Coherence Tomography Angiography Macular Analysis for Systemic Hypertension. A Systematic Review and Meta-analysis. Am J Hypertens. 2022;35(4):356–364. doi: 10.1093/ajh/hpab172</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
